First Time Loading...

Edwards Lifesciences Corp
NYSE:EW

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
NYSE:EW
Watchlist
Price: 88.61 USD 0.98% Market Closed
Updated: Apr 25, 2024

Wall Street
Price Targets

EW Price Targets Summary
Edwards Lifesciences Corp

Wall Street analysts forecast EW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EW is 96.21 USD with a low forecast of 72.72 USD and a high forecast of 110.25 USD.

Lowest
Price Target
72.72 USD
18% Downside
Average
Price Target
96.21 USD
9% Upside
Highest
Price Target
110.25 USD
24% Upside

EW Last Price Targets
Edwards Lifesciences Corp

The latest public price target was made on Apr 15, 2024 by Shagun Singh from RBC Capital , who expects EW stock to rise by 14% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Shagun Singh
RBC Capital
101 USD
Upside 14%
1 week ago
Apr 15, 2024
Edwards Lifesciences price target raised to $101 from $95 at RBC Capital
TheFly
Anthony Petrone
Mizuho Securities
105 USD
Upside 18%
2 weeks ago
Apr 11, 2024
Edwards Lifesciences price target raised to $105 from $95 at Mizuho
TheFly
Suraj Kalia
Oppenheimer
100 USD
Upside 13%
1 month ago
Mar 18, 2024
Edwards Lifesciences (EW) PT Raised to $100 at Oppenheimer
StreetInsider
Unknown Analyst
Canaccord Genuity
76 USD
Downside 14%
1 year ago
Feb 1, 2023
Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $76
Benzinga
Unknown Analyst
Truist Financial
86 USD
Downside 3%
1 year ago
Feb 1, 2023
Truist Securities Maintains Buy on Edwards Lifesciences, Raises Price Target to $86
Benzinga
Shagun Singh
RBC Capital
Price Target 101 USD
Upside/Downside 14%
View Source
Anthony Petrone
Mizuho Securities
Price Target 105 USD
Upside/Downside 18%
View Source
Suraj Kalia
Oppenheimer
Price Target 100 USD
Upside/Downside 13%
View Source
Unknown Analyst
Canaccord Genuity
Price Target 76 USD
Upside/Downside 14%
View Source
Unknown Analyst
Truist Financial
Price Target 86 USD
Upside/Downside 3%
View Source
Edwards Lifesciences Corp Competitors:
Price Targets
MDT
Medtronic PLC
19% Upside
SGHT
Sight Sciences Inc
2% Upside
CODX
Co-Diagnostics Inc
124% Upside
AORT
Artivion Inc
17% Upside
6669
Acotec Scientific Holdings Ltd
175% Upside
002432
Andon Health Co Ltd
57% Downside
605186
Shanghai General Healthy Information and Technology Co Ltd
32% Upside
IRTC
iRhythm Technologies Inc
22% Upside

Revenue
Forecast

Revenue Estimate
Edwards Lifesciences Corp

For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's revenue is 12%. The projected CAGR for the next 3 years is 10%.

12%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Edwards Lifesciences Corp

For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's operating income is 13%. The projected CAGR for the next 3 years is 12%.

13%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Edwards Lifesciences Corp

For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's net income is 14%. The projected CAGR for the next 3 years is 15%.

14%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EW's stock price target?
Price Target
96.21 USD

According to Wall Street analysts, the average 1-year price target for EW is 96.21 USD with a low forecast of 72.72 USD and a high forecast of 110.25 USD.

What is Edwards Lifesciences Corp's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's revenue is 12%. The projected CAGR for the next 3 years is 10%.

What is Edwards Lifesciences Corp's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's operating income is 13%. The projected CAGR for the next 3 years is 12%.

What is Edwards Lifesciences Corp's Net Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's net income is 14%. The projected CAGR for the next 3 years is 15%.